Greg A. Rosenfeld
St. Paul's Hospital
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.
Journal: Pharmacoepidemiology and drug safety
Published: September 29, 2025
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 15, 2025
Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 04, 2025
Gut microbiome predictors of advanced therapy response in Crohn's disease: protocol for the OPTIMIST prospective, longitudinal, observational pilot study in Canada.
Journal: BMJ open
Published: March 13, 2025
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study.
Journal: The American journal of gastroenterology
Published: January 20, 2025
The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: January 18, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.
Journal: BMJ open gastroenterology
Published: September 27, 2024
Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: September 02, 2024
Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada.
Journal: Journal of the Canadian Association of Gastroenterology
Published: August 14, 2024
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 02, 2023
A Rare Case of Gastric Extranodal NK/T-Cell Lymphoma With Orbital Involvement.
Journal: ACG case reports journal
Published: August 08, 2023
Last Updated: 09/26/2026